News & Insights

NuView Life Sciences Provides Corporate Update On NV-VPAC1 Theranostic for Breast Cancer  10.5.22

Press Release

PARK CITY, UT  NuView Life Sciences, Inc ("NuView", the "company"), is a clinical stage precision oncology company focusing on innovative approaches, such as theranostics, to diagnose and treat cancer.      read more

Advancements in Cancer Treatment - Targeting VPAC1 Receptors for Imaging Glioblastoma  1.25.22

Research Article

Malignant glioblastoma (MG) is the most common primary tumor of the cerebral hemisphere [1]. Glioblastoma multiforme, among them, is highly malignant and present poor prognosis. Despite the advances in treatment of MG, the disease remains largely incurable [2, 3].   read more

Global Expansion -

NuView Life Sciences Creates Subsidiary for Latin American Market 11.7.21

Press Release
PARK CITY, UT   NuView Life Sciences, Inc (“NuView”, the “company”), a clinical-stage oncology company focusing on innovative approaches to diagnose and treat cancers establishes NuView LATAM (“NV-LATAM”) in Mexico City.     read more

Sign up for important updates and announcements.

Sign up to receive instant updates

Contact Us